Echocardiography, commonly referred to as cardiac ultrasound or an “echo”, generates visual images of the heart known as echocardiograms. This imaging technique is especially informative during the peripartum period, the time encompassing before, during, and immediately after pregnancy. Preeclampsia is associated with an increased risk of cardiovascular disease which can show up in an echo.
A study conducted at NYU Langone Hospital aimed to assess the impact of routine postpartum echocardiograms on the management of patients diagnosed with severe preeclampsia. Researchers compared two groups: those who received echocardiograms after delivery and those who did not. The researchers wanted to see if having an echocardiogram affected hospital stay length, use of diuretics, adjustments in antihypertensive medication, and readmission rates.
The study included 356 patients, with 145 undergoing postpartum echocardiograms. Findings showed that patients who received echocardiograms had longer hospital stays (median of 5 days compared to 4), were more likely to receive diuretics, and had increased adjustments in their antihypertensive medication dosage. These patients were also more likely to be readmitted.
Further analysis within the echocardiogram group revealed that those with abnormal echo results experienced even longer hospital stays and a greater likelihood of receiving diuretics. However, there was no significant difference in the adjustment of antihypertensive medications or readmission rates between those with normal and abnormal echo results.
The study suggests that echocardiograms are often ordered for patients displaying more severe symptoms of preeclampsia, rather than the echocardiograms themselves prompting changes in management.
Take Home Message: The results indicate that postpartum echocardiograms can help identify patients with severe preeclampsia who may benefit from more intensive management strategies. Future research is encouraged to focus on detailed analyses of cardiac structure and function in these patients, which would require a larger sample size to enhance findings.
Link: https://www.ajog.org/article/S0002-9378(24)00450-2/pdf
Citation: Kantorowska, A., Corbo, A. M., Akerman, M. B., Gubernikoff, G., Kinzler, W. L., Vintzileos, A. M., & Rekawek, P. (2024). The value of maternal echocardiography after delivery in patients with severe preeclampsia. American Journal of Obstetrics and Gynecology. https://doi.org/10.1016/j.ajog.2024.03.021
Your story is needed to improve outcomes for moms like you. Add your voice to critical preeclampsia research to ensure that every story is heard.
Frequently asked questions about the Preeclampsia Registry, a patient-driven registry and biobank.
The Preeclampsia Foundation offers research funding, study recruitment, and other patient engagement services to researchers.
We provide research grant funding to advance progress towards detection, prevention, or treatment of preeclampsia, HELLP syndrome, and other hypertensive disorders of pregnancy.
Preeclampsia is a major cause of maternal and fetal morbidity and mortality. Prompt and accurate diagnosis is necessary to prevent adverse outcomes. A study was completed to determine the accura...
Predicting preeclampsia has proven to be a challenge. Researchers have documented many differences in early pregnancy between those who eventually develop preeclampsia and those who do not. These incl...
The U.S. Preventive Services Task Force (USPSTF) and American College of Obstetricians and Gynecologists (ACOG) guidelines changed in 2021 to help prevent preeclampsia. Low-dose aspirin has been shown...
Hypertensive disorders of pregnancy (HDP), including preeclampsia, affect 1 in 6 pregnancies. HDP is a general term for a range of mild to severe outcomes. Until now there has not been a reliabl...
Although there is no definitive treatment for preeclampsia, early screening and detection can allow patients to ensure proper management throughout the remainder of the pregnancy. Currently, preeclam...